Dr.Reddys Laboratories | DRRD - Sales Revenues

Stock Price
1,315.50
Daily Change
9.00 0.69%
Monthly
6.11%
Yearly
16.88%
Q1 Forecast
1,256.07

Dr.Reddys Laboratories reported INR87.27B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Aspen Pharmacare ZAR 21.4B 557M Jun/2025
Bharat Petroleum INR 1.09T 0 Dec/2025
Cipla INR 75.18B 710M Dec/2025
Dr.Reddys Laboratories INR 87.27B 780M Dec/2025
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
UPL INR 123.61B 3.42B Dec/2025